Efficacy and safety of H-APC in Barrett's esophagus: Italian prospective multicenter study
Endoscopy International Open · 26.02.2025 · 13 (CP)
DOI: 10.1055/a-2531-8227 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endoscopy International Open, erschienen am 26.02.2025. Verfasst von Davide Massimi und 14 weiteren Autor:innen. Beteiligte Einrichtung: Digestive Endoscopy Unit, Department of Gastroenterology, IRCCS Humanitas Research Hospital, Rozzano, Italy. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Hybrid argon plasma coagulation (H-APC) is a novel technique for ablation of neoplastic Barrett's esophagus (BE), consisting in submucosal fluid injection and subsequent APC of visible BE. The aim of this study was to assess H-APC efficacy, safety, and tolerability. We prospectively included patients undergoing H-APC ablation at four Italian Hospitals from September 2022 to March 2024. Patients with BE C3M5 maximum extent, low- or high-grade dysplasia (LGD, HGD) or residual BE after endoscopic resection (ER) of visible lesions were included. Patients who had undergone previous ablative treatments were excluded. The primary endpoints were complete eradication of intestinal metaplasia (CE-IM) and dysplasia (CE-D). Secondary endpoints were safety in terms of major and minor adverse events (AEs) and tolerability, assessed using pain (0–10) and dysphagia (0–5) scores within 7 days post-ablation (NCT05645679). Among the 51 enrolled patients (mean circumferential 0.43 cm; standard deviation [SD] 0.72, mean maximum longitudinal 2.20 cm; SD 1.09) who completed treatment (80 H-APC sessions), 45.1% (23/51) had prior ER of visible lesions. All patients achieved both CE-IM and CE-D (51/51), requiring a mean of 1.51 sessions (SD 0.83). Only one case of fever and absolute dysphagia was observed (1/51; 1.96% AEs). Regarding tolerability, mean pain score was 1.3 (SD 1.99) whereas mean dysphagia score was 1.28 (SD 0.56). The H-APC technique showed promising results in terms of effectiveness and safety with good tolerability in achieving initial CE-IM and CE-D in a selected population of BE patients.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Digestive Endoscopy Unit, Department of Gastroenterology, IRCCS Humanitas Research Hospital, Rozzano, Italy.
- Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Italy.
- Digestive Endoscopy Unit, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Roma, Italy.
- Digestive Endoscopy Unit, Campus Bio-Medico University Hospital, Roma, Italy.
- Endoscopy Unit, Ospedale San Giovanni Bosco, Torino, Italy.
ORCID-Profile: Davide Massimi, Silvia Pecere, Antonio Capogreco, Marco Spadaccini
Zitieren
APA
Massimi, D., Maselli, R., Pecere, S., Spada, C., Andrisani, G., Di Matteo, F. M., La Terra, A., Coppola, F., Capogreco, A., De Sire, R., Alfarone, L., Menini, M., Spadaccini, M., Hassan, C., & Repici, A. (2025). Efficacy and safety of H-APC in Barrett's esophagus: Italian prospective multicenter study. Endoscopy International Open, 13(CP). https://doi.org/10.1055/a-2531-8227
Vancouver
Massimi D, Maselli R, Pecere S, Spada C, Andrisani G, Di Matteo FM, et al. Efficacy and safety of H-APC in Barrett's esophagus: Italian prospective multicenter study. Endoscopy International Open. 2025;13(CP). doi:10.1055/a-2531-8227
BibTeX
@article{Massimi2025,
author = {Massimi, Davide and Maselli, Roberta and Pecere, Silvia and Spada, Cristiano and Andrisani, Gianluca and Di Matteo, Francesco Maria and La Terra, Antonella and Coppola, Franco and Capogreco, Antonio and De Sire, Roberto and Alfarone, Ludovico and Menini, Maddalena and Spadaccini, Marco and Hassan, Cesare and Repici, Alessandro},
title = {Efficacy and safety of H-APC in Barrett's esophagus: Italian prospective multicenter study},
journal = {Endoscopy International Open},
year = {2025},
volume = {13},
number = {CP},
doi = {10.1055/a-2531-8227}
}
EUVIMED